A discussion of key issues in relation to short incubation (rapid) HIV testing in a non-clinical setting. This presentation By Stevie Clayton of ACON was given at the AFAO AGM workshops November 2007.
This document discusses how expanding the scope of pharmacy practice to include point-of-care testing, screenings, immunizations, and initiating or modifying drug therapy under collaborative practice agreements could help advance population health outcomes and address issues like a shortage of primary care providers and increased needs of an aging population. It provides examples of how allowing pharmacists to perform rapid strep and flu tests and treat based on the results could provide more access points for care. The benefits of engaging pharmacists as healthcare providers and examples of previous expansions that have been successful are also summarized.
Clinical trials are research studies that test whether medical treatments, procedures, devices, or lifestyle changes are safe and effective for humans. They can determine which approaches work best for certain conditions or groups of people. Without clinical trials, it would not be possible to develop new drugs or improve medical care. Clinical trials involve giving precise interventions to participants according to the study design and comparing outcomes. The results of clinical trials contribute significantly to medical knowledge and help improve future patient health by providing information on the benefits and risks of new and existing treatments. It is important for potential volunteers to research all aspects of a clinical trial, such as its purpose, procedures, risks, time commitment, and compensation, before agreeing to participate.
Comprehensive pharmacy services | Point of caredanielbrain10
Learn about our comprehensive pharmacy solutions at the point of care that allow physicians to improve clinical outcomes and increase patient satisfaction.
PFCC INFOGRAPHIC: Six Steps to Patient EngagementEngagingPatients
The challenges of creating patient and family-centered care seem daunting. However, the PFCC Innovation Center of UPMC demonstrates it's easier than you think. In this infographic, you see it begins by engaging patients through a simple six step process.
This document discusses how patient engagement changes processes from a FOTO perspective. It summarizes that patient engagement allows for targeted discussions focused on the patient, quantifies a patient's ability to function, and provides fair comparisons of patients to similar cases to predict outcomes. This helps patients learn expected results, how many visits are needed, and how much improvement to expect, which increases patient commitment and provides consistent feedback through individualized reports.
FOTO helps patients learn about themselves and how they compare to similar patients by having them complete efficient online tests on any device. This provides information to both patients and doctors, answering questions about a patient's anticipated results, how long it may take to achieve them, and how many visits may be required.
The document discusses creating a sustainable culture of quality in pharmaceutical manufacturing. It emphasizes that quality should go beyond just compliance with regulations and include testing drugs to ensure they are safe, effective with the correct identity, will perform consistently over the shelf life, and are manufactured in a way that ensures quality. Mistakes should be shared with management without fear. The goal is to establish a quality mindset where it is assumed that drugs will meet all quality standards and be available when patients need them.
A discussion of key issues in relation to short incubation (rapid) HIV testing in a non-clinical setting. This presentation By Stevie Clayton of ACON was given at the AFAO AGM workshops November 2007.
This document discusses how expanding the scope of pharmacy practice to include point-of-care testing, screenings, immunizations, and initiating or modifying drug therapy under collaborative practice agreements could help advance population health outcomes and address issues like a shortage of primary care providers and increased needs of an aging population. It provides examples of how allowing pharmacists to perform rapid strep and flu tests and treat based on the results could provide more access points for care. The benefits of engaging pharmacists as healthcare providers and examples of previous expansions that have been successful are also summarized.
Clinical trials are research studies that test whether medical treatments, procedures, devices, or lifestyle changes are safe and effective for humans. They can determine which approaches work best for certain conditions or groups of people. Without clinical trials, it would not be possible to develop new drugs or improve medical care. Clinical trials involve giving precise interventions to participants according to the study design and comparing outcomes. The results of clinical trials contribute significantly to medical knowledge and help improve future patient health by providing information on the benefits and risks of new and existing treatments. It is important for potential volunteers to research all aspects of a clinical trial, such as its purpose, procedures, risks, time commitment, and compensation, before agreeing to participate.
Comprehensive pharmacy services | Point of caredanielbrain10
Learn about our comprehensive pharmacy solutions at the point of care that allow physicians to improve clinical outcomes and increase patient satisfaction.
PFCC INFOGRAPHIC: Six Steps to Patient EngagementEngagingPatients
The challenges of creating patient and family-centered care seem daunting. However, the PFCC Innovation Center of UPMC demonstrates it's easier than you think. In this infographic, you see it begins by engaging patients through a simple six step process.
This document discusses how patient engagement changes processes from a FOTO perspective. It summarizes that patient engagement allows for targeted discussions focused on the patient, quantifies a patient's ability to function, and provides fair comparisons of patients to similar cases to predict outcomes. This helps patients learn expected results, how many visits are needed, and how much improvement to expect, which increases patient commitment and provides consistent feedback through individualized reports.
FOTO helps patients learn about themselves and how they compare to similar patients by having them complete efficient online tests on any device. This provides information to both patients and doctors, answering questions about a patient's anticipated results, how long it may take to achieve them, and how many visits may be required.
The document discusses creating a sustainable culture of quality in pharmaceutical manufacturing. It emphasizes that quality should go beyond just compliance with regulations and include testing drugs to ensure they are safe, effective with the correct identity, will perform consistently over the shelf life, and are manufactured in a way that ensures quality. Mistakes should be shared with management without fear. The goal is to establish a quality mindset where it is assumed that drugs will meet all quality standards and be available when patients need them.
The role of the patient in improving qualityUCLPartners
This document discusses the role of patients in improving healthcare quality. It notes that traditionally, quality improvement efforts have focused on monitoring outcomes and provider ratings. However, social media platforms and online communities now allow patients to directly share their experiences and assess quality of care. Studies show patients who connect with others online report better management of conditions like epilepsy and more control over their care. When patients can openly discuss their conditions, strategize treatments, and evaluate different providers, it empowers them to take a more active role in improving overall healthcare quality.
This document reports on a survey of patients using an electronic patient health record system called Patients Know Best (PKB). 119 patients with home parenteral nutrition were recruited over 18 months to use PKB. A survey of 58 users found high satisfaction, with most finding PKB useful for contacting nurses, doctors, and dietitians. The survey results suggest patients find PKB a useful tool for managing their long-term condition and improving communication between their healthcare team.
1. The document discusses the importance of creating and maintaining a culture of quality in pharmaceutical manufacturing. It outlines several key aspects of a quality culture, including a focus on continuous improvement, willingness to identify and address issues, and an understanding that quality is everyone's responsibility.
2. Maintaining a quality culture requires leadership commitment to reinforce the right behaviors and decision making. Quality culture can deteriorate quickly if management loses focus on it or faces pressures like cost reductions. Early indicators of issues need to be addressed immediately.
3. The document provides examples of metrics that can help measure quality culture, such as the number of reported deviations, complaints, and process failures. A strong quality culture helps ensure product quality is not compromised
Nursing home self assessment surveys and patient satisfactionCare Analytics
Care Analytics assessments are important because they give you a realistic view of what is happening in the day-to-day practice of your facility. They help you sort out problems that need considerable work from issues that appear to be working reasonably well and perhaps need only staff reminders to be on
track. Unlike surveys in which you try to put your best foot forward, this is a survey that requires you to look at both feet honestly and constructively.
Dr Avi Ratnanesan is the Chief Executive Officer of Energesse, a leading firm that specialises in improving patient experience and customer experience in healthcare. Energesse provides thought leadership in patient-centred innovation and technology solutions including MES Experience for real-time patient feedback and PanSensic for free-text analytics of patient stories.
At the RACMA Conference Talked about how to use machine learning to improve patient feedback as well as building the rules engine to advise on patient experience improvement. Here are some of the slides and stories shared at the conference which seem to be received very well.
This document discusses the challenges facing emergency departments, including increasing patient volumes, pressure to improve satisfaction scores, and changes to reimbursement policies. It proposes automating patient follow-up after discharge as a solution to check on patients' progress, engage with them about care, and manage high-utilizing patients more efficiently. Hospitals that have implemented automated follow-up saw improved satisfaction scores, better patient care, and increased organizational efficiency.
Over half of patients at a rehabilitation hospital reported wanting greater involvement in their care decisions. To address this, the hospital conducted patient and family shadowing where observers followed patients to experience care from their perspective. This identified themes like explanations during rounds and involvement in discharge plans. A post-intervention survey found a statistically significant improvement in patients feeling involved in care decisions and clinically relevant improvements in understanding doctor explanations and recommending the hospital. Engaging medical leaders and balancing data with reflection time led doctors to change practices without formal rules.
The document discusses creating a sustainable culture of quality in the pharmaceutical industry. It provides examples of key quality metrics such as lot acceptance rate, product quality complaint rate, and invalidated OOS rate that can be used to measure the state of quality. It also identifies attributes that are essential for a quality culture, such as leadership emphasis on quality, message credibility, peer involvement, and employee ownership. The document emphasizes that a strong quality culture is needed to support an efficient quality system and outlines some of the visible signals and roots of a strong quality culture.
The patient experience describes an individual's experience of illness/injury and how healthcare treats them. Good patient experience is very helpful for healthcare industry. Many hospitals and clinics use patient experience surveys to identify where they stand in the term of Patient Experience.
Dr. Eric Moore - 2016 Antibiotic Symposium Review & Survey EvaluationJohn Blue
2016 Antibiotic Symposium Review & Survey Evaluation - Dr. Eric Moore, Director of Technical Services, North America, Norbrook, Inc., from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Marwan Sabbagh, MD, FAAN, CCRI, prepared useful Practice Aids pertaining to Alzheimer's disease for this CME activity titled, "Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?" For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2FBgpZ0. CME credit will be available until January 29, 2020.
Gamification as a means to manage chronic diseaseEngagingPatients
UPMC is exploring ways to better engage patients through shared decision making and new approaches to encourage patients and their families to take control of their health. This presentation describes a pilot program UPMC has initiated to leverage gamification as a means to manage chronic heart failure.
The Patient Experience Response Program is an innovative physician-patient feedback service that delivers strong ROI. It connects patients to their prescribers to gather end-to-end feedback on experiences with products and services, with an emphasis on the user experience. Physicians encourage appropriate patients to enroll in surveys that capture important measures of brand awareness, appreciation, and overall treatment satisfaction. Physicians then receive reports on their patients' experiences to inform future conversations during office visits and reinforce the value of the brand. The program aims to increase uptake, encourage trials, capture market share, and counter misleading information through the facilitated patient-physician communication.
Independent School Health Professionals should participate in the 2015 Research Questionnaire about independent school health services. And here are 5 reasons why!
The Beryl Institute 2013 State of the Patient Experience Benchmarking StudyEngagingPatients
This document summarizes the key findings of a survey of over 1,000 US hospitals regarding their efforts to improve the patient experience. It finds that while patient experience remains a top priority, hospitals feel somewhat less positive about their progress than two years ago. Most hospitals now have a formal definition and structure for patient experience. Leadership support and HCAHPS scores are the top factors driving patient experience work. Hospitals continue focusing on communication, noise reduction, and discharge processes to improve patient experience.
Over the summer of 2015, the Vocera Experience Innovation Network launched a study to identify ways healthcare leaders in the United States and Canada are improving quality, safety, and increasing efficiency while also enhancing patient, family and staff experience.
More than 100 senior level healthcare executives completed an online survey or participated in one-on-one qualitative interviews to provide insight into their organization's strategic initiatives, emerging best practices, and operational infrastructures designed to drive improvement. Survey and interview findings outlined in this presentation reveal gaps in communication, infrastructure, and stakeholder engagement as many hospitals and health systems still struggle to align quality, safety and experience strategies.
This deck represents a few key findings from the study. To download the full report, click here: http://solutions.vocera.com/HumanizingEfficiencySurvey.html?utm_source=PR
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Ajaz Hussain
Sharing thoughts on what makes a Good Regulator of Pharmaceuticals with pharmacy students at the Universities of Minnesota and Iowa. A point of emphasis on "we all are regulators" is explained and three areas for learning - (a) Systems and Integrative Thinking, (b) Argumentation and (c) Behavioral Economics described.
I hope you, the viewers, will also find some value in reviewing these slides. If you are a student and have some questions please feel free to drop me a email (a2zpharmsci@msn.com).
This document provides guidance on evaluating product recalls. It discusses factors to consider such as hazard evaluation, population segmentation, seriousness of hazards, and consequences. Examples of recall scenarios are presented and questions are provided to facilitate discussion. Attendees are encouraged to discuss real cases and how they would be handled. The goal is to enhance understanding of recall strategies and decision making.
The role of the patient in improving qualityUCLPartners
This document discusses the role of patients in improving healthcare quality. It notes that traditionally, quality improvement efforts have focused on monitoring outcomes and provider ratings. However, social media platforms and online communities now allow patients to directly share their experiences and assess quality of care. Studies show patients who connect with others online report better management of conditions like epilepsy and more control over their care. When patients can openly discuss their conditions, strategize treatments, and evaluate different providers, it empowers them to take a more active role in improving overall healthcare quality.
This document reports on a survey of patients using an electronic patient health record system called Patients Know Best (PKB). 119 patients with home parenteral nutrition were recruited over 18 months to use PKB. A survey of 58 users found high satisfaction, with most finding PKB useful for contacting nurses, doctors, and dietitians. The survey results suggest patients find PKB a useful tool for managing their long-term condition and improving communication between their healthcare team.
1. The document discusses the importance of creating and maintaining a culture of quality in pharmaceutical manufacturing. It outlines several key aspects of a quality culture, including a focus on continuous improvement, willingness to identify and address issues, and an understanding that quality is everyone's responsibility.
2. Maintaining a quality culture requires leadership commitment to reinforce the right behaviors and decision making. Quality culture can deteriorate quickly if management loses focus on it or faces pressures like cost reductions. Early indicators of issues need to be addressed immediately.
3. The document provides examples of metrics that can help measure quality culture, such as the number of reported deviations, complaints, and process failures. A strong quality culture helps ensure product quality is not compromised
Nursing home self assessment surveys and patient satisfactionCare Analytics
Care Analytics assessments are important because they give you a realistic view of what is happening in the day-to-day practice of your facility. They help you sort out problems that need considerable work from issues that appear to be working reasonably well and perhaps need only staff reminders to be on
track. Unlike surveys in which you try to put your best foot forward, this is a survey that requires you to look at both feet honestly and constructively.
Dr Avi Ratnanesan is the Chief Executive Officer of Energesse, a leading firm that specialises in improving patient experience and customer experience in healthcare. Energesse provides thought leadership in patient-centred innovation and technology solutions including MES Experience for real-time patient feedback and PanSensic for free-text analytics of patient stories.
At the RACMA Conference Talked about how to use machine learning to improve patient feedback as well as building the rules engine to advise on patient experience improvement. Here are some of the slides and stories shared at the conference which seem to be received very well.
This document discusses the challenges facing emergency departments, including increasing patient volumes, pressure to improve satisfaction scores, and changes to reimbursement policies. It proposes automating patient follow-up after discharge as a solution to check on patients' progress, engage with them about care, and manage high-utilizing patients more efficiently. Hospitals that have implemented automated follow-up saw improved satisfaction scores, better patient care, and increased organizational efficiency.
Over half of patients at a rehabilitation hospital reported wanting greater involvement in their care decisions. To address this, the hospital conducted patient and family shadowing where observers followed patients to experience care from their perspective. This identified themes like explanations during rounds and involvement in discharge plans. A post-intervention survey found a statistically significant improvement in patients feeling involved in care decisions and clinically relevant improvements in understanding doctor explanations and recommending the hospital. Engaging medical leaders and balancing data with reflection time led doctors to change practices without formal rules.
The document discusses creating a sustainable culture of quality in the pharmaceutical industry. It provides examples of key quality metrics such as lot acceptance rate, product quality complaint rate, and invalidated OOS rate that can be used to measure the state of quality. It also identifies attributes that are essential for a quality culture, such as leadership emphasis on quality, message credibility, peer involvement, and employee ownership. The document emphasizes that a strong quality culture is needed to support an efficient quality system and outlines some of the visible signals and roots of a strong quality culture.
The patient experience describes an individual's experience of illness/injury and how healthcare treats them. Good patient experience is very helpful for healthcare industry. Many hospitals and clinics use patient experience surveys to identify where they stand in the term of Patient Experience.
Dr. Eric Moore - 2016 Antibiotic Symposium Review & Survey EvaluationJohn Blue
2016 Antibiotic Symposium Review & Survey Evaluation - Dr. Eric Moore, Director of Technical Services, North America, Norbrook, Inc., from the 2017 NIAA Annual Conference, U.S. Animal Agriculture's Future Role In World Food Production - Obstacles & Opportunities, April 4 - 6, Columbus, OH, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2017_niaa_us_animal_ag_future_role_world_food_production
Marwan Sabbagh, MD, FAAN, CCRI, prepared useful Practice Aids pertaining to Alzheimer's disease for this CME activity titled, "Taking Stock of Potential Advances in the Early Diagnosis of Alzheimer’s Disease: What Are the Implications for Treatment?" For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2FBgpZ0. CME credit will be available until January 29, 2020.
Gamification as a means to manage chronic diseaseEngagingPatients
UPMC is exploring ways to better engage patients through shared decision making and new approaches to encourage patients and their families to take control of their health. This presentation describes a pilot program UPMC has initiated to leverage gamification as a means to manage chronic heart failure.
The Patient Experience Response Program is an innovative physician-patient feedback service that delivers strong ROI. It connects patients to their prescribers to gather end-to-end feedback on experiences with products and services, with an emphasis on the user experience. Physicians encourage appropriate patients to enroll in surveys that capture important measures of brand awareness, appreciation, and overall treatment satisfaction. Physicians then receive reports on their patients' experiences to inform future conversations during office visits and reinforce the value of the brand. The program aims to increase uptake, encourage trials, capture market share, and counter misleading information through the facilitated patient-physician communication.
Independent School Health Professionals should participate in the 2015 Research Questionnaire about independent school health services. And here are 5 reasons why!
The Beryl Institute 2013 State of the Patient Experience Benchmarking StudyEngagingPatients
This document summarizes the key findings of a survey of over 1,000 US hospitals regarding their efforts to improve the patient experience. It finds that while patient experience remains a top priority, hospitals feel somewhat less positive about their progress than two years ago. Most hospitals now have a formal definition and structure for patient experience. Leadership support and HCAHPS scores are the top factors driving patient experience work. Hospitals continue focusing on communication, noise reduction, and discharge processes to improve patient experience.
Over the summer of 2015, the Vocera Experience Innovation Network launched a study to identify ways healthcare leaders in the United States and Canada are improving quality, safety, and increasing efficiency while also enhancing patient, family and staff experience.
More than 100 senior level healthcare executives completed an online survey or participated in one-on-one qualitative interviews to provide insight into their organization's strategic initiatives, emerging best practices, and operational infrastructures designed to drive improvement. Survey and interview findings outlined in this presentation reveal gaps in communication, infrastructure, and stakeholder engagement as many hospitals and health systems still struggle to align quality, safety and experience strategies.
This deck represents a few key findings from the study. To download the full report, click here: http://solutions.vocera.com/HumanizingEfficiencySurvey.html?utm_source=PR
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Ajaz Hussain
Sharing thoughts on what makes a Good Regulator of Pharmaceuticals with pharmacy students at the Universities of Minnesota and Iowa. A point of emphasis on "we all are regulators" is explained and three areas for learning - (a) Systems and Integrative Thinking, (b) Argumentation and (c) Behavioral Economics described.
I hope you, the viewers, will also find some value in reviewing these slides. If you are a student and have some questions please feel free to drop me a email (a2zpharmsci@msn.com).
This document provides guidance on evaluating product recalls. It discusses factors to consider such as hazard evaluation, population segmentation, seriousness of hazards, and consequences. Examples of recall scenarios are presented and questions are provided to facilitate discussion. Attendees are encouraged to discuss real cases and how they would be handled. The goal is to enhance understanding of recall strategies and decision making.
The document outlines the journey of a startup called Pesticide.ID in developing a product to provide consumers transparency about pesticide residues in food. It describes 5 phases of customer research conducted with over 100 interviews. Phase 1 involved interviews with health conscious consumers. Phase 2 involved retailers. Phase 3 involved farmers, distributors and suppliers. Phase 4 scouted other market opportunities. Phase 5 pivoted the focus to new parents based on research findings. The journey continues to test and validate the business model through an MVP and generating social media traction.
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences minAjaz Hussain
Improving Confidence in Quality of Medicines . We make two products – medicine and evidence (documents) but many forget this and do not pay attention to documentation.
Level of attention to documentation is a “canary in a coal mine”
Breaches are irrational –”System 1 thinking” and cognitive biases.
Culture of Quality is familiar to all of us – a framework proposed
Quality Metrics – great idea – very much needed; but we are not yet ready for an FDA Guidance.
We must first address our collective blind spots; be confident that process validation truly ensures complexity is sufficiently reduced and that outcomes are predictable.
The document discusses the need for the FDA to better regulate the dietary supplements industry in order to protect public safety. It notes that the billion dollar industry is currently under less stringent regulation than the pharmaceutical industry since supplements are classified as foods rather than drugs. This could allow unsafe products to reach consumers without proper testing or oversight. The authors propose several steps for the FDA to take including implementing pre-market regulations to review products for safety, educating consumers, and increasing independent case studies to hold manufacturers accountable. The goal is to ensure supplements are reliable and consumers can make informed choices to avoid potential health issues like mortality from overuse or contaminated products.
The document discusses the need for the FDA to better regulate the dietary supplements industry in order to protect public safety. It notes that the billion dollar industry is currently under less stringent regulation than the pharmaceutical industry, despite supplements sometimes having detrimental health effects. The authors propose that the FDA implement pre-market regulations and testing of supplements, educate consumers, and conduct more case studies to hold manufacturers accountable and remove unsafe products from the market. This would help ensure that supplements are reliable and that consumers are informed of benefits and risks.
The document provides information about Drug Information Centres (DIC). It defines a DIC as a service that provides advice and refers queries about drugs to appropriate resources. DICs aim to promote evidence-based practice and improve patient care. They classify DICs as hospital-based, industry-based, or community-based. Clinical pharmacists working in DICs provide written or verbal drug information to healthcare professionals and patients. They respond to queries about various drug attributes like indications, dosages, interactions and side effects. When answering drug information questions, pharmacists gather background details, clarify the question, search multiple sources for relevant data, interpret the findings and formulate an appropriate response to address the query.
Presentation for spbt 2013 meeting background and researchklaffy
The document discusses the changing context of medical practice and the need for pharmaceutical representatives to build value-based relationships with physicians. It provides guidance on how representatives can validate their clinical knowledge through sub-specialty certification programs. The document also summarizes research that found physicians are more likely to meet with representatives who have completed specialized training programs developed by medical societies. Finally, it outlines the structure and attributes of an ideal disease-state training program for representatives.
Learn the disconnect between regulatory traceability requirements & industry standards; how KDEs needed for recall resolution compare to those in FSMA 204; & ways to fortify your traceability system
Mark Behl Presents: Five Hurdles in Population HealthMark Behl
Population health is a burgeoning field that holds great potential for revolutionizing the way that healthcare is carried out. But before this potential can be realized, there are some hurdles that need be overcome.
Becoming Better Advocates for Your HealthBest Doctors
A leader and innovator in research on patient-centered care, Dr. Leana Wen will share her perspectives on what patients and providers can do to work more effectively together to achieve their shared goal – better health and outcomes. She will be joined by Sonia Millsom, VP of Best Doctors, who will discuss how optimizing care and controlling costs are within reach for today’s patient. The presenters will finish with live questions from the audience.
This document provides background information on dietary supplement regulation in the United States. The Dietary Supplement Health and Education Act of 1994 established that supplements do not require FDA approval before going to market. This has led to safety concerns as supplements can be sold without testing. The document also discusses a study that found physicians have poor knowledge of supplement regulation. The author then outlines their methods for selecting supplements to research and provide recommendations on, which included a literature review of supplement safety. Key recommendations included whey and casein protein, branched chain amino acids, glutamine, creatine, and beta-alanine as supplements with research supporting their safety and benefits for athletes.
Patients and their loved ones often hold critical knowledge that informs diagnosis. This toolkit from the Institute of Medicine offers patients, families and clinicians guidance on how they can collaborate to improve diagnosis.
Special Challenges in Clinical Trials: Case Study: the Dying child and the ...Michael Swit
A review of a case study involving whether it would be proper to authorize the use of a drug whose approval had been withdrawn when it is believed to be the only hope for a dying child.
This document summarizes regulatory perspectives on approving drugs for rare diseases from a presentation given by an FDA official. It provides an overview of drug development for rare diseases before and after the 1983 Orphan Drug Act. While the Act increased incentives for rare disease drug development, approval challenges remain due to small patient populations and lack of understanding of rare diseases. The FDA aims to apply flexibility in effectiveness standards and innovative trial designs and analyses. Ongoing collaborations between the FDA, industry, academia, and patient groups are needed to continue advancing treatments for rare diseases.
In this webinar, you will learn:
How we approach intervention campaigns: a framework
The science of behavior change and how it can be applied to increase the probability of desired outcomes
How Altarum’s ACE Measure can help predict consumer behaviors and design successful intervention campaigns
Speakers:
Ryan Rossier, Medullan
Chris Duke, Altarum
Josh Klapow, ChipRewards
5 Reasons the Practice of Evidence-Based Medicine Is a Hot TopicHealth Catalyst
Evidence-based medicine is an important model of care because it offers health systems a way to achieve the goals of the Triple Aim. It also offers health systems an opportunity to thrive in this era of value-based care. In specific, there are five reasons the industry is interested in the practice of evidence-based medicine: (1) With the explosion of scientific knowledge being published, it’s difficult for clinicians to stay current on the latest best practices. (2) Improved technology enables healthcare workers to have better access to data and knowledge. (3) Payers, employers, and patients are driving the need for the industry to show transparency, accountability, and value. (4) There is broad evidence that Americans often do not get the care they need. (5) Evidence-based medicine works. While the practice of evidence-based medicine is growing in popularity, moving an entire organization to a new model of care presents challenges. First, clinicians need to change how they were taught to practice. Second, providers are already busy with increasingly larger and larger workloads. Using a five-step framework, though, enables clinicians to begin to incorporate evidence-based medicine into their practices. The five steps include (1) Asking a clinical question to identify a key problem. (2) Acquiring the best evidence possible. (3) Appraising the evidence and making sure it’s applicable to the population and the question being asked. (4) Applying the evidence to daily clinical practice. (5) Assessing performance.
20131210 Electronic Health Records - Is the NHS ready? What about patientsamirhannan
On 12th December 2013, Dr Hannan (GP / family physician) along with Marilyn Gollom (patient) presented this talk to Health 2.0 Manchester. You can watch the talk by going to http://www.htmc.co.uk/pages/pv.asp?p=htmc0519.
Drug Utilization in a regulated EnviormentAlok Anand
Tracking drugs across the supply chain in a regulated environment. This white paper brief on would be drug utilization approach of Life Science Industry. This white paper is just a step forward to show future life science industry process automation
Similar to Ensuring You're Not The Weak Link In Food Traceability (20)
This year (2016) has seen some reasonably good news for most physicians! More than 19,500 physicians in 25 specialties responded to various surveys and describing their compensation, number of hours worked, practice changes resulting from healthcare reform, and how they have adapted to the new healthcare environment.
For more information - http://blog.audioeducator.com/physician-compensation-report-2016/
MACRA – 3 Important Medicare Payment Changes InfographicAudioEducator
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), the much awaited change in healthcare—which totally revamps Medicare (Part B) clinician payments from a fee-for-service to a value-based system is finally here.
For more information - http://blog.audioeducator.com/macra-3-important-medicare-payment-changes-infographic/
2016 healthcare predictions - 2015 was a year of changes for the healthcare industry, most notable of which was the implementation of ICD-10 coding guidelines, but it’s not over yet!
For more information - http://blog.audioeducator.com/healthcare-predictions-2016/
What's In a Label: GMO, Natural, and Organic Labeling IssuesAudioEducator
The document discusses issues around labeling terms like "GMO", "natural", and "organic". It provides an overview of current and pending labeling requirements for bioengineered foods, debates over using "all natural", and complications defining terms as food production techniques advance. Specifically, it notes that labeling issues are a significant source of litigation as consumer interest drives GMO labeling legislation. It also explains that defining "genetically engineered" is difficult and that right to know labeling laws can lead to confusing results for consumers.
Live audio conference on write, organize and maintain Standard Operating Procedures and teach personnel the methods that will ensure FDA compliance in a manner that will be reproducible, concise and easy to follow.
Urological Non Surgical Hospital Coding for 2014 AudioEducator
This document discusses coding for non-surgical urological hospital services. It notes that the concept of new or established patient does not apply, and that admission, consultative, subsequent visit, shared/split, and discharge services all have specific codes. It reviews codes for initial hospital visits (99221-99223), subsequent visits (99231-99233), and consultations (99231-99232 in place of 99251-99252, and without transfer of care requirements). The document provides an overview of special coding rules and scenarios for non-surgical urological hospital admissions and visits.
US, EU & Japan GMP Requirements: Practical ICH Area Differences & Healthcare ...AudioEducator
This document provides an overview of Good Manufacturing Practice (GMP) requirements for pharmaceutical manufacturers in the US, EU, and Japan. It discusses the different regulatory authorities for each region, including the FDA, EMA, and PMDA. The document also outlines the key topics that will be covered, such as ICH guidelines, GMP compliance and inspections, differences between regions, and specifics on FDA, EU, and Japan inspections. The goal is to highlight both the commonalities and differences in GMP standards and inspection focus internationally.
The document discusses changes to the OASIS assessment tool that will go into effect on January 1st with the implementation of OASIS C1-ICD9 version. Key points include:
- CMS made revisions to the OASIS C tool to better align it with other healthcare assessment tools like MDS and CARE while updating clinical concepts, wording, and responses.
- Agencies will now submit OASIS data directly to CMS through the new ASAP system instead of state databases starting January 1st.
- The previous OASIS submission system shuts down on December 26th and the new ASAP system begins accepting assessments on January 1st. Assessments may need to be
US Regulations for Food, Drugs, Medical Devices and CosmeticsAudioEducator
This presentation provides an overview of US regulations for food, drugs, cosmetics, and medical devices. It discusses key areas such as definitions, labeling requirements, good manufacturing practices, and regulatory requirements for investigational new drugs and devices. The presentation also covers common non-compliance issues and FDA enforcement actions. The goal is to help attendees understand US regulations in these areas and best practices for achieving and maintaining compliance.
Medicare for Eye-care: Coding and Billing GuidelinesAudioEducator
This document summarizes guidelines for coding and billing Medicare for eye care. It discusses that Medicare carriers differ by state and what is acceptable to one carrier may be denied by another. It provides an overview of Medicare basics, updates, tips for working with Medicare including understanding carrier-specific rules. Common procedures, office visits, how to appeal denied claims and preparing for ICD-10 changes are addressed. The presenter notes Medicare guidelines are very detailed and most private carriers follow Medicare guidelines. It is important to understand local coverage determinations and never bill Medicare for refraction or glasses. Tips are provided for working effectively with carriers including getting contact details and clarification in writing.
Revenue Cycle: Tracking Reimbursement for DRGs, APCs and MPFSAudioEducator
Review the reimbursement tracking as part of the revenue cycle, and understand the basics of DRGs, APCs and MPFS in this audio session with Duane Abbey.
Regulatory Compliance in the Pharmaceutical Supply ChainAudioEducator
The document summarizes key points about regulatory compliance in the pharmaceutical supply chain. It discusses how the FDA launched initiatives in 2002 to modernize drug manufacturing regulations using modern risk management and quality techniques. This was driven by an increase in adverse drug events and recalls. The FDA introduced new GMP regulations for the 21st century requiring comprehensive patient risk management and manufacturing approaches based on scientific principles. The new regulations can consider all products at a facility "adulterated" if any GMP system fails inspection, potentially wiping out revenue from a single high-risk product. The presentation provides background on these changes to FDA regulation and their impact on the pharmaceutical industry.
Recipe for Success: How to Effectively Manage an Allergen ProgramAudioEducator
Audio conference on Recipe for Success: How To Effectively Manage an Allergen Program by Valerie Scheidt – Learn steps to execute allergen procedures in daily activities.
Pediatric coding and documentation challengesAudioEducator
Understand the Various Coding and Documentation Challenges you Face for Pediatric Medical Care by Kim Garner-Huey. Webinar will update you on Pediatric CPT codes along with ICD 10 codes.
Pediatric Coding, Billing, and Compliance Update 2015AudioEducator
The document summarizes a presentation on pediatric coding, billing, and compliance updates for 2015. It discusses changes to CPT codes, diagnosis coding concerns, preparing for ICD-10, and compliance issues. Additionally, it notes two new vaccinations awaiting FDA approval and a transition to using US abbreviations for vaccines. The full presentation can be accessed at the provided link.
Medical Necessity and Recent Government Scrutiny and Theories of EnforcementAudioEducator
Know the basics of how ‘medically necessary’ services are defined by government health plans; and which often are followed by private payors in this audio session.
At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care.
For More Details:
Map: https://cutt.ly/BwCeflYo
Name: Apollo Hospital
Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012
Phone: 08429021957
Opening Hours: 24X7
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
Gemma Wean- Nutritional solution for Artemiasmuskaan0008
GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia.
GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content.
GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...nirahealhty
The South Beach Coffee Java Diet is a variation of the popular South Beach Diet, which was developed by cardiologist Dr. Arthur Agatston. The original South Beach Diet focuses on consuming lean proteins, healthy fats, and low-glycemic index carbohydrates. The South Beach Coffee Java Diet adds the element of coffee, specifically caffeine, to enhance weight loss and improve energy levels.
Unlocking the Secrets to Safe Patient Handling.pdfLift Ability
Furthermore, the time constraints and workload in healthcare settings can make it challenging for caregivers to prioritise safe patient handling Australia practices, leading to shortcuts and increased risks.
Can Allopathy and Homeopathy Be Used Together in India.pdfDharma Homoeopathy
This article explores the potential for combining allopathy and homeopathy in India, examining the benefits, challenges, and the emerging field of integrative medicine.
Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)bkling
Your mindset is the way you make sense of the world around you. This lens influences the way you think, the way you feel, and how you might behave in certain situations. Let's talk about mindset myths that can get us into trouble and ways to cultivate a mindset to support your cancer survivorship in authentic ways. Let’s Talk About It!
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfDr Rachana Gujar
The "Comprehensive Rainy Season Advisory: Safety and Preparedness Tips" offers essential guidance for navigating rainy weather conditions. It covers strategies for staying safe during storms, flood prevention measures, and advice on preparing for inclement weather. This advisory aims to ensure individuals are equipped with the knowledge and resources to handle the challenges of the rainy season effectively, emphasizing safety, preparedness, and resilience.
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
Ensuring You're Not The Weak Link In Food Traceability
1. Ensuring you're not the weak link in food traceability
Presenter - Dr. Jennifer McEntireFollow us :
Get An Action-Plan For Determining When And If Traceability Is A Necessity
For Your Business
2. Overview
Recalls vs traceability
Current requirements and industry state of play
What to expect as FDA proceeds in rulemaking
How to view traceability as more than just a cost
FDA requirements, GFSI requirements, and
industry initiatives
2
3. OutbreakInvestigation
• People get ill from something they ate
• Go to doctor?
• Doctor collects samples?
• Reported to public health?
• Samples further distinguished (molecular techniques)
• Outbreak recognized
• Go back to people and ask what they ate
• Try to find common product
• Try to find common source of the product –convergence
• This is the regulatory traceback
3
4. Grower Processor Manufacturer Distributor Retail
4
The Supply Chain
Trace Forward/ Recall:
Where is the food?
Trace Back:
What is causing illness?
6. Is Traceback Solely “After the Fact”?
Today: No
• Root cause analysis can help prevent future issues
• Public response and recovery may depend on
understanding “what happened”
In the future: No
• Can supply chain visibility help rule in/out certain
products/brands?
• Instant, accurate knowledge of supply chains can help
inform epi
6
7. To see the complete presentation check the below
link:
http://www.audioeducator.com/food-safety/regulatory-mandates-01-29-
14.html